Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    Open Studies | "Hemorrhagic Fever, Ebola"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of the cAd3-EBO and cAd3-EBOZ Ebola Vaccines in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: cAd3-EBOZ;   Biological: cAd3-EBO
2 Recruiting A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
3 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
4 Recruiting Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Condition: Hemorrhagic Fever, Ebola
Intervention: Other: Convalescent Plasma
5 Recruiting Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Condition: Hemorrhagic Fever, Ebola
Intervention: Biological: rVSVΔ-ZEBOV-GP
6 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
7 Recruiting A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
Conditions: Filovirus Infections;   Ebola Virus Infection
Interventions: Drug: BCX4430;   Drug: Placebo
8 Recruiting A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus Disease
Intervention: Biological: VSV-ZEBOV
9 Not yet recruiting Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Intervention: Biological: VRC-EBOADC069-00-vp
10 Not yet recruiting Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Condition: Ebola Virus Disease
Interventions: Drug: Best Supportive Care;   Drug: Best Supportive Care + Amiodarone
11 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOADC069-00-VP;   Biological: VRC-EBOADC076-00-VP
12 Recruiting Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
Condition: Ebola Virus
Interventions: Drug: Placebo;   Biological: VSVG-ZEBOV;   Biological: ChAd3-EBO Z

Indicates status has not been verified in more than two years